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Genetic Counseling and Testing for Breast Cancer Risk in African Americans
Abstract
Genetic testing for susceptibility to breast and ovarian cancer (BRCA1/2 testing) has been available in
clinical settings since 1996. Increasingly, such testing is helping women at increased risk make decisions
about breast cancer screening and prevention. African American women have participated in genetic
counseling and testing programs less than white women, despite greater rates of early onset disease and
higher breast cancer mortality. The barriers and motivations for genetic testing among African American
women are not well understood. This Issue Brief summarizes a series of studies that systematically
explore African American women’s beliefs and intentions about BRCA1/2 testing. The findings have been
used to tailor genetic counseling programs to better serve this population.
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Racial disparities in the
use of BRCA1/2 testing
exist, but the reasons for
low African American
participation are not
known

Although hereditary breast cancer accounts for only about 5%-10% of all breast
cancer cases, women who carry a BRCA1/2 mutation have a 55%-85% lifetime risk
of developing breast cancer, and a 15%-60% lifetime risk of developing ovarian
cancer. In addition to providing personal risk information, genetic test results also
have important implications for family members. The U.S. Preventive Services Task
Force recommends that women with a family history suggestive of hereditary breast
cancer be referred for genetic counseling so that they can make informed decisions
about whether to undergo genetic testing.

Editor’s note: Genetic testing for susceptibility to breast and ovarian cancer
(BRCA1/2 testing) has been available in clinical settings since 1996. Increasingly,
such testing is helping women at increased risk make decisions about breast cancer
screening and prevention. African American women have participated in genetic
counseling and testing programs less than white women, despite greater rates of early
onset disease and higher breast cancer mortality. The barriers and motivations for
genetic testing among African American women are not well understood. This Issue
Brief summarizes a series of studies that systematically explore African American
women’s beliefs and intentions about BRCA1/2 testing. The findings have been used
to tailor genetic counseling programs to better serve this population.

• African American participation in BRCA1/2 counseling and testing programs,
and in research about hereditary breast cancer, is low. In a report describing
10,000 consecutive BRCA1/2 laboratory analyses in the U.S., fewer than 2% of
blood samples came from women of African descent. A recent study found that
African American women with a family history of breast or ovarian cancer were
significantly less likely to undergo genetic counseling for BRCA1/2 testing than
white women with a similar family history, a disparity that was not explained by
the probability of carrying a BRCA1/2 mutation, socioeconomic status, cancer
risk perception and worry, or attitudes about BRCA1/2 testing.
• Previous studies have evaluated racial differences in knowledge and attitudes
about genetic testing or have compared African American and white women’s
intentions to be tested. These studies have shown that knowledge about breast
cancer genetics and exposure to information about the availability of testing is low
among African Americans, whereas expectations about the benefits of genetic
testing are high.
Continued on next page.

• After considering the benefits and harms of genetic testing and possible preventive
measures, not all women at increased risk for hereditary breast cancer will choose
to have BRCA1/2 testing. Even if women ultimately decide not to have testing,
participation in genetic counseling may be useful for African American women to
increase knowledge about breast cancer risk factors and to provide information
about options for cancer prevention and control.
• Barriers to utilization of genetic tests among African Americans may include the
cost and availability of testing, concerns about exploitation, and distrust of the
medical community. Cultural beliefs and values may also influence decisions
about participating in genetic counseling and testing; however, little is known
about cultural and attitudinal barriers and facilitators of participation specifically
among African Americans.

Communalism and
religious coping style may
influence genetic testing
decisions among African
Americans

To explore how cultural beliefs and values might affect decisions about genetic
testing among African Americans, Halbert and colleagues interviewed 28 African
American women at increased risk for developing breast cancer, based on their
family history. The women were recruited through mammography and oncology
clinics and were invited to participate in a genetic counseling and testing research
program.
• The interviewers explored previously identified aspects of an African American
worldview, including communalism (social and familial interdependence),
spirituality (religious coping style), and flexible temporal orientation (with an
emphasis on both past and present dimensions). In addition, they assessed
fatalistic beliefs about cancer, which has been associated with decreased use of
cancer screening tests in African Americans.
• Overall, 61% of women accepted genetic counseling and testing, and 39%
declined. Test acceptors had higher levels of fatalism about cancer, lower levels of
perceived familial interdependence, and were more oriented toward the future.
• Participation rates were lower among women reporting that individuals should
not view themselves as independent from family members. Although previous
studies suggest that higher levels of spirituality about disease causation may be a
barrier to participation in genetic testing, women who reported greater use of
working together with God in difficult situations were more likely to accept
genetic testing in this study. These findings suggest that beliefs and values
regarding communalism and religious coping style could be used as a basis for
providing culturally sensitive genetic counseling to African American women.

African American women
have a favorable view of
genetic testing, but voice
concern about its impact
on family

Prior to their participation in a randomized study of alternative models of genetic
counseling, 74 African American women at high or moderate risk of having a
BRCA1/2 mutation were interviewed to evaluate their attitudes about the benefits,
limitations, and risks of genetic testing and their intentions to be tested.
• Consistent with previous studies, most women reported positive attitudes about
genetic testing. Although the benefits of genetic testing were generally endorsed,
only 30% of women indicated that they would definitely be tested. About onethird of women said that they were not considering genetic testing.
• The most important benefit of genetic testing was to know if additional steps are
needed to prevent cancer (88% rated very important) whereas the most important

limitation or risk of genetic testing was concern about the impact on family
members (25% rated very important).
• Adjusting for other factors, women with a personal history of breast cancer and
those who perceived themselves at highest risk for breast cancer were more likely
to report negative attitudes toward genetic testing than other women. However,
women with a high perceived risk were also more likely to consider genetic testing
than women with a lower perceived risk. In addition, women with more than two
affected relatives, and women who believed that cancer screening generates fear,
were more likely to consider genetic testing than other women.

Developing a culturally
tailored genetic counseling
program

Halbert and colleagues used their findings to develop a culturally tailored genetic
counseling (CTGC) protocol for African Americans. CTGC differs from standard
genetic counseling in that it incorporates discussion of beliefs and values related to
spirituality and religion, temporal orientation, and communalism. The CTGC
sessions last about two hours, about a half an hour longer than the standard sessions.
• To address religious and spiritual beliefs and values, women are asked, “What role
does spirituality play in your life and what aspect of your religious and spiritual
beliefs would influence your decision to have genetic testing?”
• To address values related to temporal orientation, women are asked, “When you
make choices about your health care, are you focused on what is going on now or
focused on events that may happen in the future?”
• The CTGC protocol also includes probes that encourage women to discuss family
concerns. For example, women are asked to describe how their family
experiences with breast and/or ovarian cancer influenced their decisions to have
genetic counseling, if they talked to any of their family members about
participating in genetic counseling, and how they would feel if their family did
not want to them to have genetic testing.

Culturally tailored
counseling may be
beneficial for African
American women

The researchers are conducting a randomized study of the effects of CTGC and
standard counseling among African American women at increased risk for hereditary
breast and ovarian cancer. After extensive outreach efforts in clinics and community
events, 62% of eligible women enrolled in the study, and 50% chose to participate
in genetic counseling.
• In a sample of 54 women who participated in pre-test education and counseling,
women were equally and strongly satisfied with genetic counseling in both the
CTGC and standard counseling groups (96% being very satisfied). However, only
26% reported that their worries were lessened and 22% reported that they were
able to cope better.
• Women receiving CTGC were significantly more likely to report that their
worries were lessened than women receiving standard counseling. In addition,
women with household incomes less than $35,000 were less likely to report that
their worries were lessened compared to women with higher incomes.
• These results suggest that discussion of cultural beliefs and values may be beneficial
for African American women, especially those with low incomes. Ongoing
analyses will compare the effects of CTGC and standard genetic counseling on
decisions about genetic testing, psychological functioning, and health behaviors.
Continued on back.

POLICY IMPLICATIONS

As genetic testing for susceptibility to breast cancer becomes integrated into the
clinical management of high-risk women, it is critical to identify ways to enhance
access to counseling services for women from underserved minority groups. By
focusing on values and culture specific to African Americans, these studies have
informed the development of counseling services that might be more effective for
this population.
• Outreach is needed to improve African American women’s knowledge about the
availability of genetic counseling and testing for susceptibility to breast cancer.
Outreach efforts should include a more elaborate discussion about the impact of
testing on family relationships.
• It is likely that cultural beliefs and values that influence participation in genetic
testing also influence psychological and behavioral reactions to test results.
Therefore, it may be beneficial to incorporate these aspects of the African
American cultural worldview into discussions with women after they receive their
test results as well.
• Because genetic counseling services are most often prompted by a physician
referral, continuing efforts are needed to overcome racial disparities in access to
primary and preventive care.
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